Bruker Corporation logo BRKRP - Bruker Corporation

Price: -- --
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Platform & Compounding FCF 50% confidence

Primary model: Two-stage FCF DCF

Valuation Signal Overvalued Strong
Trading 106834.4% above fair value
Current Price $420.49
Bear Case $0.00 100.0% downside ($0.00 - $420.49) / $420.49 = -100.0% 5% stage 1 growth, 12% discount
Fair Value $0.39 99.9% downside ($0.39 - $420.49) / $420.49 = -99.9% 9% stage 1 growth, 12% discount
Bull Case $2.82 99.3% downside ($2.82 - $420.49) / $420.49 = -99.3% 11% stage 1 growth, 12% discount

Adjust Assumptions

8.6%
12.0%
3.0%

Key Value Driver

FCF growth rate (9% base case)

Terminal Value % of EV 33%
Implied Market Multiple 618.5x
Market is pricing in (growth) 59.2% vs our 8.6% base

Plain-Language Summary

Using a two-stage FCF DCF with 9% growth decelerating over 15 years, discounted at 12%, the base-case intrinsic value is $0.39 per share.

Key Risks

  • P/E alone misleads — earnings depressed by growth investment
  • Cyclical or commodity businesses may be misclassified as platforms
  • Terminal value dominance suggests sensitivity to long-run assumptions